Analysts Viewpoint
The Potential Rise in the Price of Immunome Inc (IMNM) following insiders activity
In a filing, Immunome Inc revealed its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
Menu
In a filing, Immunome Inc revealed its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
Immunome Inc’s recently made public that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
Immunome Inc’s filing revealed that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03 ’25.
Immunome Inc’s recently made public that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Immunome Inc’s recent filing unveils that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Immunome Inc revealed its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Immunome Inc’s filing revealed that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03 ’25.